Bring breakthrough therapy to your clinic.

Wavelengths
Wavelengths

Pioneering technology. Promising results.

Spinal cord injury (SCI) is a life-altering condition that results in partial or complete loss of motor and sensory function below the level of injury. The World Health Organization estimates that between 250,000 and 500,000 new cases occur each year. With therapy, support, and assistive devices, most people with SCI are able to improve their strength and mobility, and adapt to the effects of their injuries—but they may still struggle with daily tasks like showering, dressing, and preparing meals. ExaStim was developed to help people with SCI regain lost movement, strength, and functionality, so they can enjoy greater independence.

Science

Understanding the Science Behind ExaStim® Technology

The brain sends and receives nerve signals that control movement—and the spinal cord carries these signals from the brain to the rest of the body. Spinal cord injuries can damage nerve fibers, causing changes in feeling, movement, strength, and body function. ANEUVO’s ExaStim platform uses safe, non-invasive electrical stimulation to re-engage the nervous system and re-activate neural circuitries, helping to restore lost movement, strength, and body function.

Approach

A Non-Invasive Approach to Neuromodulation

ExaStim provides therapy without the risks and complications of surgery. As a non-invasive device, it delivers spinal stimulation via 16 electrodes on a flexible pad that adheres to the skin and moves with the body.

  • 16-Channel Multi-Electrode Array
    Personalizes therapy to the patient
  • Flexible Stimulation Settings
    Enable activation of different muscle groups
  • Intuitive Programming Interface
    Easy for patients and caregivers to use

Application

Advanced technology. Simple usability.

ExaStim is easy to use. Clinicians control therapy through an intuitive, app-based platform on a familiar touchscreen tablet. Lightweight, portable, and rechargeable, ExaStim provides convenient, accessible therapy from any location.

  • Highly customizable programming
    Set electrode parameters independently, in combination or sequentially (e.g. amplitude, pulse width, frequency)
  • Individualize settings based on desired motor response
    Activate different muscle groups individually or together
  • Streamlined UI for simplified testing and programming
    Generate reports, track therapy, save treatments and more

Support for clinicians.
Peace of mind for their patients.

Contact Us

ANEUVO in the News

ANEUVO has been featured by leading news networks, business and health podcasts, and science and research conferences around the world. Learn more about our company, our technology, and individuals’ experiences with transcutaneous spinal stimulation and the ExaStim Stimulation System in the stories below.

Content Categories

ANEUVO Receives FDA Clearance for ExaStim<sup><sup>®</sup></sup>

ANEUVO Receives FDA Clearance for ExaStim®

U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...

Read more
Investigational therapy helps Easthampton man regain movement after spinal cord injury

Investigational therapy helps Easthampton man regain movement after spinal cord injury

EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...

Read more
ANEUVO Secures Series C Funding to Strengthen ExaStim<sup>®</sup> Regulatory Readiness and Global Operational Scale

ANEUVO Secures Series C Funding to Strengthen ExaStim® Regulatory Readiness and Global Operational Scale

Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...

Read more
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim<sup>®</sup> Neuromodulation Technology

ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology

Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...

Read more
ANEUVO Showcases ExaStim<sup>®</sup> Therapy At RehaCare 2025 and ISCoS 2025

ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025

The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...

Read more
ANEUVO’s ExaStim<sup>®</sup> Earns CE Mark Certification

ANEUVO’s ExaStim® Earns CE Mark Certification

Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...

Read more
ANEUVO Launches ASPIRE<sup>™</sup> Home Study to Evaluate Home Use of ExaStim<sup>®</sup>

ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®

This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...

Read more
Massachusetts skier faces uphill climb after ‘worst possible injury imaginable’

Massachusetts skier faces uphill climb after ‘worst possible injury imaginable’

BOSTON — Michael Feinberg has had three years to think about the moment on the ski slope that changed his life forever. “It’s horrifying,” he...

Read more
View More